EMAIL THIS PAGE TO A FRIEND

Archives of toxicology

Comparison of xenobiotic metabolizing enzyme activities in ex vivo human skin and reconstructed human skin models from SkinEthic.


PMID 24658324

Abstract

Skin function is not limited to a physical barrier. According to its total surface area, it is also considered as an extra-hepatic metabolizing organ. In vitro engineered human skins have been developed to replace limited ex vivo normal human skin samples (NHS). Thus, assessing and comparing skin models from SkinEthic [Episkin™, RHE™ and the full thickness model (FTM)] with NHS in terms of metabolic capability are essential. The apparent activities of main cutaneous isoforms of cytochrome P450-dependent monooxygenases (CYP1A1/1B1, 2B6/2C18/2E1, 3A5/3A7), esterase, glutathione-S-[(GST), A, M, P, T], N-acetyl-(NAT1), uridinyl-diphosphate glucuronyl-(UDPGT 1A family) and sulfo-(SULT1A1) transferases were determined using probe substrates. Mean activities indicative of CYP1A1/1B1 (expressed as pmol/mg protein/6 h) in RHE™ (2.8) and FTM (2.6) were very similar to NHS (3.0) while Episkin™ showed a higher activity (9.1). Activities of CYP3A5/3A7 in FTM (3.3) and Episkin™ (3.6) were similar to NHS (3.8) while activity in RHE™ (13.3) was higher. CYP2B6/2C18/2E1 activity was below LOQ (0.5) in all skin models and NHS. Comparable intrinsic metabolic clearances were measured between NHS and skin models for esterase, UDPGT, GST and NAT1 activities. SULT1A1 activity toward probe substrates was not detected in skin models and observed at the limit of detection in NHS. Weak cytochrome P450-dependent monooxygenases, high esterase and transferase activities suggested that NHS and skin models exhibited limited functionalization and much greater detoxification (hydrolytic and conjugating) capacities. These results demonstrate that skin models are similar to NHS in terms of metabolic functionality toward xenobiotics investigated and useful tools to assess both the local efficiency and safety of cosmetics.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

45966
1,3-Dinitrobenzene, analytical standard
C6H4N2O4
41980
1,3-Dinitrobenzene, for HPLC derivatization, for the detection of steroids
C6H4N2O4
D194255
1,3-Dinitrobenzene, 97% anhydrous basis
C6H4N2O4
442244
1,3-Dinitrobenzene, analytical standard
C6H4N2O4
237329
1-Chloro-2,4-dinitrobenzene, ≥99%
C6H3ClN2O4
138630
1-Chloro-2,4-dinitrobenzene, 97%
C6H3ClN2O4
W503401
2,4-Dimethylthiazole, ≥95%, FG
C5H7NS
133337
4-Acetamidobenzoic acid, 98%
C9H9NO3
852910
4-Aminobenzoic acid sodium salt, 99%
C7H8NNaO2
A6928
4-Aminobenzoic acid sodium salt, ≥99%, powder
C7H6NNaO2
M1381
4-Methylumbelliferone, ≥98%
C10H8O3
M0883
4-Methylumbelliferyl acetate, esterase substrate
C12H10O4
1048
4-Nitrophenol, spectrophotometric grade
C6H5NO3
35836
4-Nitrophenol, PESTANAL®, analytical standard
C6H5NO3
241326
4-Nitrophenol, ReagentPlus®, ≥99%
C6H5NO3
48549
4-Nitrophenol, Reference Material
C6H5NO3
PHR1150
4-NITROPHENOL (Acetaminophen Related Compound F)(Paracetamol Impurity F), Pharmaceutical Secondary Standard; Certified Reference Material
C6H5NO3
N7660
4-Nitrophenol solution, 10 mM
C6H5NO3
40056
4-Nitrophenol solution, certified reference material, 5000 μg/mL in methanol
C6H5NO3
43575
4-Nitrophenol solution, stock solution, for mass spectrometry
C6H5NO3
49053
4-Nitrophenol solution, working solution, for mass spectrometry
C6H5NO3
B5057
7-Benzyloxy-4-trifluoromethylcoumarin, ≥99% (HPLC), solid
C17H11F3O3
A35801
Allyl sulfide, 97%
C6H10S
W204218
Allyl sulfide, ≥97%, FG
C6H10S
40647
Allyl sulfide, analytical standard
C6H10S
72609
Coumarin, certified reference material, TraceCERT®
C9H6O2
C4261
Coumarin, ≥99% (HPLC)
C9H6O2
W526509
Coumarin, ≥98%
C9H6O2
01260595
Coumarin, primary pharmaceutical reference standard
C9H6O2
Y0000438
Coumarin, European Pharmacopoeia (EP) Reference Standard
C9H6O2